ESC 365 - Iron supplementation: how, when and in which patients.

Back

Iron supplementation: how, when and in which patients.

Session: HFA Webinars 2020

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor P. Kalra (Portsmouth, GB) Professor E. Jankowska (Wroclaw, PL) Professor A. Voors (Groningen, NL)

Event: HFA Webinar

Add to my library

About the speakers

Professor Paul Kalra

Queen Alexandra Hospital, Portsmouth (United Kingdom of Great Britain & Northern Ireland)

9 presentations

3 followers

Professor Ewa Anita Jankowska

Wroclaw Medical University, Wroclaw (Poland)

62 presentations

5 followers

Professor Adriaan Voors

University Medical Centre Groningen, Groningen (Netherlands (The))

77 presentations

1 follower

10 more presentations in this session

How to optimise RAASi therapy in patients with hyperkalaemia.

Access

Next generation RNA therapeutics. Background and clinical development in cardiovascular disease.

Speaker: Professor T. Thum (Hannover, DE) Professor G. Condorelli (Milan, IT) Professor R. De Boer (Rotterdam, NL)

Access

Video

Access the full session

HFA Webinars 2020

Speakers: Professor P. Kalra, Professor E. Jankowska, Professor A. Voors, Professor T. Thum, Professor G. Condorelli...

Access

About the event

HFA Webinar

1 January - 31 December 2099

Sessions Presentations

ESC 365 is supported by

Explore sponsored resources

Iron supplementation: how, when and in which patients.

About the speakers

Professor Paul Kalra

Professor Ewa Anita Jankowska

Professor Adriaan Voors

10 more presentations in this session

How to optimise RAASi therapy in patients with hyperkalaemia.

Next generation RNA therapeutics. Background and clinical development in cardiovascular disease.

The evidence from clinical trials.

Current and future perspective on heart failure treatment

Optimal Implementation of HF Therapies: guidelines and challenges.

Access the full session

HFA Webinars 2020

About the event

HFA Webinar

ESC 365 is supported by